People with #HereditaryAgioedema (#HAE) have a personal choice of two distinct therapeutic strategies based on clinical assessment: treatment of attacks (on-demand) or prevention of attacks (prophylactic). Our goal is to develop novel, oral on-demand and prophylactic alternatives with #deucrictibant — the only oral B2 receptor antagonist currently in clinical development for the treatment of HAE to our knowledge. Visit our website to learn more about how our treatment strategy aims to improve the quality of life for people with HAE: https://lnkd.in/gzNk4GdP #ClinicalTrials #HAEtreatment
Pharvaris’ Post
More Relevant Posts
-
👉 Exciting news in the fight against alcohol-use disorder! A recent study published reveals that Novo Nordisk's semaglutide, a GLP-1 receptor agonist, might significantly reduce the risk of AUD recurrence. The findings suggest that patients receiving semaglutide had up to a 56% lower risk of relapse. While more research is needed, this adds to the growing list of benefits from this remarkable drug. Check out the article for more details! ⬇ #HealthcareInnovation #AddictionRecovery #Semaglutide
To view or add a comment, sign in
-
-
New study uncovers how GPCRs, particularly the vasopressin V2 receptor (V2R), continue to signal from internalized compartments, highlighting the role of βarrestin (βarr) and Gβγ in non-canonical endosomal signaling. Discover how these mechanisms can pave the way for innovative therapeutic strategies. Check out the latest GPCR news in the Ecosystem today! You’ll need to register, but don’t worry, it’s Free! ➡️https://bit.ly/4d9yUQ3 #GPCR #DrGPCR
To view or add a comment, sign in
-
-
We are excited to share that Caitlyn Durgin is first author on this paper providing evidence of prominent differences in opioid response profiles that are present at opioid (hydromorphone) initiation. Developers of non-mu, opioid receptor agonist targets for treatment of pain, take note! Access the paper here, https://lnkd.in/eDWDEk-g #pain #opioid #clinicaldevelopment #data #drugdevelopment #personalizedmedicine
To view or add a comment, sign in
-
-
“Mean body weight (kg) of participants taking #Semaglutide or a placebo over a two year observational trial." © 2022 Garvey et al. It’s clear Semaglutide, also known as #Ozempic and #Wegovy is a potent weight loss solution, but how does it truly work? Discover the effectiveness of this GLP-1 receptor agonist for weight loss and #Type2Diabetes in our most recent article, available here 🔽 https://bit.ly/47C40hi #ClinicalTrials #ObesityResearch
To view or add a comment, sign in
-
-
ScRNAseq analysis revealed the characteristics of CD4+ T cells in ACS, which could be therapeutic targets of ACS. @Emoto_Takuo https://lnkd.in/gScJKFA7
To view or add a comment, sign in
-
-
Reduction of Pannexin 1 rejuvenated senescent EPCs in therapeutic angiogenic potential through augmentation of IGF-1 https://lnkd.in/gyuN7e5S
To view or add a comment, sign in
-
-
Learn about the results of an open-label, long-term safety and tolerability analysis of adult patients in a phase 2/3 clinical trial of a CGRP receptor antagonist for the acute treatment of #migraine. These findings were published in the April edition of Cephalalgia.
To view or add a comment, sign in
-
Learn about the results of an open-label, long-term safety and tolerability analysis of adult patients in a phase 2/3 clinical trial of a CGRP receptor antagonist for the acute treatment of #migraine. These findings were published in the April edition of Cephalalgia. #PFEColleague
Learn about the results of an open-label, long-term safety and tolerability analysis of adult patients in a phase 2/3 clinical trial of a CGRP receptor antagonist for the acute treatment of #migraine. These findings were published in the April edition of Cephalalgia.
New Publication Alert: CGRP Receptor Antagonist for the Acute Treatment of Migraine
To view or add a comment, sign in
-
Sequential, multistep activation mechanism of metabotropic glutamate receptor subtype 5. Just out. https://lnkd.in/dCaR7J96
Stepwise activation of a metabotropic glutamate receptor - Nature
nature.com
To view or add a comment, sign in
-
ENDO-TAGS :designed proteins that stimulate endocytosis of cell surface receptors for receptor lysosomal degredation by inducing receptor conformational change or dimerisation/ clustering. Many potential therapeutic possibilities here. #endocytosis #receptors #PROTACS #proteindesign #endolysosome #drugdesign https://lnkd.in/eTnB-Tk3
To view or add a comment, sign in
Head of Global Equity Research
1moIntellia NTLA is progressing in trials for ATTR and Heteditary angiodaema using CRISPR technology